Column GROUP Ii, L.P. is 10% Owner at RAPT Therapeutics, Inc. (RAPT). They have made 6 open-market trades across 2 companies since 2019, most recently 2023-01-12.
CIK 0001600420
5 open-market purchases totalling $765K since 2019, against 1 sale. Across 5 scored buys the stock is up 25.6% at ninety days, and 20.8 points ahead of the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 80% | 80% | 40% |
| Avg Move | +7.2% | +11.5% | +25.6% |
| Alpha | +7.1% | +10.6% | +20.8% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NGM | BUY | 2023-01-12 | 2023-01-17 | $4.95 | $27K | -3.6% | -11.9% | -25.8% |
| RAPT | BUY | 2022-05-25 | 2022-05-27 | $12.45 | $24K | +8.1% | +28.6% | +108.2% |
| RAPT | SELL | 2021-09-14 | 2021-09-16 | $37.01 | $13.0M | -13.3% | -19.3% | -19.1% |
| NGM | BUY | 2019-10-17 | 2019-10-21 | $11.18 | $464K | +8.9% | +23.6% | +54.7% |
| NGM | BUY | 2019-08-08 | 2019-08-09 | $13.99 | $2K | +12.3% | +12.1% | -8.3% |
| NGM | BUY | 2019-05-10 | 2019-05-13 | $13.85 | $248K | +10.2% | +5.3% | -0.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.